Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price36.46
Ethical score30.0/100
RatingOVERVALUED
Our investment reviews on this name
2026-10-25Read Markdown35.67+2.2% to today Distribution gives way to Markdown
2026-10-18Read Distribution35.67+2.2% to today Markup gives way to Distribution first Distribution read since October
2026-10-11Read Markup36.62-0.4% to today Distribution gives way to Markup first Markup read since July
2026-08-15Read Distribution38.33-4.9% to today ✓Markup gives way to Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Saturna Al-Kawthar World Equity ETF holds its Markdown at $36.46. The statistical read favours the sellers, held for 5 days.
As held on the ledger · 2026-10-28
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 5 days
Price at the screen
$36.46
Valuation
26.35 trailing · N/A forward price to earnings
Values screen
PASS· score 30.0
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Shariah-screened global equity ETF
Fail
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Saturna Al-Kawthar World Equity ETF clears all five screens. Its business is in a permissible area, its debt, cash, receivables and income are all inside the lines, so it passes.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when UMMA's ethical verdict changes
Today UMMA passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads OVERVALUED
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
UMMA trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-25Markdown · changed$35.67+0.0%Entry 9
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.6% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 25% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
2026-10-11Markup · changed$36.62+0.0%Entry 7
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 25% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
2026-10-02Distribution$36.62-4.5%Entry 6
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.5% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 25% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
2026-09-15Distribution$38.33+0.0%Entry 5
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 25% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 25% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
2026-07-18Markup$38.33+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 25% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
2026-07-03Markup$38.33+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$38.33Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The Political Ledger · Congressional Disclosures
Disclosures naming UMMA
Date
Politician
Party
Type
Amount
2026-05-08
Bill Keating
Democrat
Purchase
1K–15K
2026-03-27
Alan Armstrong
Republican
buy
1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
Period
Price then
Price return
Divs per share
$1,000 became
Total return
1 month
$36.53
-0.1%
·
$999
-0.1%
2 months
$32.86
+11.0%
·
$1,110
+11.0%
3 months
$31.29
+16.6%
$0.12
$1,170
+17.0%
6 months
$29.31
+24.5%
$0.12
$1,249
+24.9%
1 year
$26.05
+40.1%
$0.36
$1,414
+41.4%
2 years
$24.42
+49.4%
$0.58
$1,518
+51.8%
3 years
$21.25
+71.7%
$0.77
$1,753
+75.3%
Historical returns from market close data. Past performance does not guarantee future results.
The Ledger's Promise
This entry now belongs to the ledger. Whatever UMMA does next, these words stay.
Saturna Al-Kawthar World Equity ETF · UMMA · Markdown · $36.46
Recorded 2026-10-28 · before the outcome · scored mechanically
